Most of HCC patients are diagnosed with advanced stage at the first diagnosis1, 2 The more patients with higher tumor stages and the lower HER2 expression in general, might account for no significant change of ERBB2 mRNA between liver cancer and normal liver in TCGA cohort. The gene discussed is ERBB2; the disease is hepatocellular carcinoma.